Pain Diabetic Peripheral Neuropathy(DPN) in China
Clinical Characteristics and Treatment of Pain Diabetic Peripheral Neuropathy(DPN) in China: a Multi-center Cross-sectional Survey
Clinical Characteristics and Treatment of Pain Diabetic Peripheral Neuropathy(DPN) in China: a Multi-center Cross-sectional Survey
Sponsor study identifier
observational
1,500
1 country
1
Study Start
April 1, 2018
Actual (reported)Primary Completion
October 1, 2018
Actual (reported)Study Completion
October 1, 2018
Actual (reported)To understand the clinical characteristics of DPN patients in China; To investigate the distribution of DPN patients with depression and anxiety symptoms; To investigate the related factors of moderate and severe pain in DPN patients; To investigate the treatment of pain and depression and/or anxiety in DPN patients.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 1, 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 1, 2018
Actual (reported)October 1, 2018
Actual (reported)October 1, 2018
Actual (reported)June 29, 2020
Actual (reported)July 2, 2020
Actual (reported)moderate and severe pain (VAS score ≥4)
The correlation factors of moderate and severe pain (VAS score ≥4) were analyzed exploratively. A Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured. Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.
Time at recruitment
Demographic data
Time at recruitment
Clinical manifestations of pain: VAS score
Time at recruitment
Depression screening/assessment: PHQ-9 scale
Time at recruitment
Anxiety screening/assessment: GAD-7 scale
Time at recruitment
Neuropathic pain is the focus of current clinical research, clinical identification, and treatment. It is unique from nociceptive pain and requires evaluation of the relevance and utility of common pain measures created for other painful conditions.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Pain diabetic peripheral neuropathy(DPN) in China
Peking University Third Hospital
Beijing, China
Dongsheng Fan, MD.PHD
Peking University Third Hospital
1,500 participants (actual enrollment reported by the registry).
First Submitted
June 29, 2020
First Posted
July 2, 2020
Study Start
April 1, 2018
Actual (reported)Role of Synchronized Lifestyle Modification Program in Insulin Dependent Diabetic Peripheral Neuropathy Patients
Contact the study team to confirm eligibility.
Primary Completion
October 1, 2018
Actual (reported)Study Completion
October 1, 2018
Actual (reported)Last Updated
July 2, 2020
Record last verified: 2020-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: